MiR-4521 perturbs FOXM1-mediated DNA damage response in breast cancer
Open Access
- 21 March 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 10, 1131433
Abstract
Introduction: Forkhead (FOX) transcription factors are involved in cell cycle control, cellular differentiation, maintenance of tissues, and aging. Mutation or aberrant expression of FOX proteins is associated with developmental disorders and cancers. FOXM1, an oncogenic transcription factor, is a promoter of cell proliferation and accelerated development of breast adenocarcinomas, squamous carcinoma of the head, neck, and cervix, and nasopharyngeal carcinoma. High FOXM1 expression is correlated with chemoresistance in patients treated with doxorubicin and Epirubicin by enhancing the DNA repair in breast cancer cells.Method: miRNA-seq identified downregulation of miR-4521 in breast cancer cell lines. Stable miR-4521 overexpressing breast cancer cell lines (MCF-7, MDA-MB-468) were developed to identify miR-4521 target gene and function in breast cancer.Results: Here, we showed that FOXM1 is a direct target of miR-4521 in breast cancer. Overexpression of miR-4521 significantly downregulated FOXM1 expression in breast cancer cells. FOXM1 regulates cell cycle progression and DNA damage response in breast cancer. We showed that miR-4521 expression leads to increased ROS levels and DNA damage in breast cancer cells. FOXM1 plays a critical role in ROS scavenging and promotes stemness which contributes to drug resistance in breast cancer. We observed that breast cancer cells stably expressing miR-4521 lead to cell cycle arrest, impaired FOXM1 mediated DNA damage response leading to increased cell death in breast cancer cells. Additionally, miR-4521-mediated FOXM1 downregulation perturbs cell proliferation, invasion, cell cycle progression, and epithelial-to-mesenchymal progression (EMT) in breast cancer.Discussion: High FOXM1 expression has been associated with radio and chemoresistance contributing to poor patient survival in multiple cancers, including breast cancer. Our study showed that FOXM1 mediated DNA damage response could be targeted using miR-4521 mimics as a novel therapeutic for breast cancer.Keywords
Funding Information
- Anusandhan National Research Foundation (YSS/2015/001051 CRG/2020/004681)
- Indian Council of Medical Research (2019-0278/GEN-BMS)
This publication has 55 references indexed in Scilit:
- FoxM1 is Overexpressed in Helicobacter pylori–Induced Gastric Carcinogenesis and Is Negatively Regulated by miR-370Molecular Cancer Research, 2013
- FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair GeneRad51Clinical Cancer Research, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- miR‐134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non‐small cell lung cancer cellsFEBS Letters, 2012
- Suppression of FOXM1 Sensitizes Human Cancer Cells to Cell Death Induced by DNA-DamagePLOS ONE, 2012
- FoxM1, a critical regulator of oxidative stress during oncogenesisThe EMBO Journal, 2009
- FoxM1 Regulates Transcription of JNK1 to Promote the G1/S Transition and Tumor Cell InvasivenessJournal of Biological Chemistry, 2008
- miRDB: A microRNA target prediction and functional annotation database with a wiki interfaceRNA, 2008
- TarBase: A comprehensive database of experimentally supported animal microRNA targetsRNA, 2005
- Loss of the Forkhead Transcription Factor FoxM1 Causes Centrosome Amplification and Mitotic CatastropheCancer Research, 2005